ClinCalc Pro
Menu
Macrolide antibiotic Pregnancy: Use only if benefit outweighs risk — some reports of cardiovascular defects. Avoid in first trimester if possible.

Clarithromycin (ENT Indications)

Brand names: Klaricid

Adult dose

Dose: 250–500 mg twice daily for 5–14 days
Route: Oral or IV
Frequency: Twice daily
Max: 500 mg twice daily (1 g/day)
Tonsillitis/pharyngitis (penicillin allergy): 250 mg BD for 5 days. Acute sinusitis (penicillin allergy): 250–500 mg BD for 5 days. Community pneumonia (atypicals): 500 mg BD. H. pylori triple therapy: 500 mg BD + amoxicillin + PPI. IV: 500 mg BD for severe infections.

Paediatric dose

Dose: 7.5 mg/kg
Route: Oral
Frequency: Twice daily
Max: 500 mg/dose
Concentration: 125 mg/ml
1 month–11 years: 7.5 mg/kg BD (max 250 mg BD standard; 500 mg BD severe). 12–17 years: adult dose. Granules or suspension for younger children (125 mg/5 mL).

Dose adjustments

Renal

If eGFR <30: halve dose or double interval. Avoid prolonged high-dose use.

Hepatic

Avoid in severe hepatic disease; caution in moderate impairment.

Paediatric weight-based calculator

1 month–11 years: 7.5 mg/kg BD (max 250 mg BD standard; 500 mg BD severe). 12–17 years: adult dose. Granules or suspension for younger children (125 mg/5 mL).

Clinical pearls

  • Alternative to amoxicillin for penicillin-allergic patients with respiratory/ENT infections
  • Active against Group A Streptococcus, Moraxella, H. influenzae (limited), atypical organisms
  • Significant CYP3A4 inhibitor — numerous drug interactions
  • Metallic taste common — take with food to reduce GI side effects
  • AVOID with simvastatin or lovastatin — statin myopathy risk

Contraindications

  • QT prolongation or Torsades de Pointes history
  • Concomitant use of QT-prolonging drugs
  • Hypersensitivity to macrolides

Side effects

  • GI upset (nausea, abdominal pain, diarrhoea)
  • Metallic taste
  • QT prolongation
  • Elevated liver enzymes
  • Antibiotic-associated colitis
  • Hearing disturbance (high doses)

Interactions

  • Statins (simvastatin, atorvastatin) — increased myopathy risk (avoid combination or reduce statin dose)
  • Warfarin — significantly increases INR
  • Ciclosporin, tacrolimus — increased levels
  • Colchicine — increased toxicity (avoid if renal/hepatic impairment)
  • Carbamazepine — increased carbamazepine levels

Monitoring

  • LFTs (prolonged use)
  • Drug interactions
  • ECG (if QT risk)

Reference: BNFc; BNF; BNFc; PHE ENT Antimicrobial Guidelines. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.